Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Soloway

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2018
Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic SignatureSoum D Lokeshwar, Asif Talukder, Travis J Yates, et al.
The Journal of Urology|December 14, 2012
A multi-institutional evaluation of active surveillance for low risk prostate cancerScott E Eggener, Alex Mueller, Ryan K Berglund, et al.
The Journal of Urology|February 24, 2009
A multi-institutional evaluation of active surveillance for low risk prostate cancerScott E Eggener, Alex Mueller, Ryan K Berglund, et al.
World Journal of Urology|August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancerMario I Fernández, Maurizio Brausi, Peter E Clark, et al.
Oncogenesis|May 20, 2020
Molecular targeting of renal cell carcinoma by an oral combinationAndre R Jordan, Jiaojiao Wang, Travis J Yates, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settingsCora N Sternberg, Joaquim Bellmunt, Guru Sonpavde, et al.
Cancer Cell International|December 29, 2022
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinomaJiaojiao Wang, Andre R Jordan, Huabin Zhu, et al.
British Journal of Cancer|October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targetsDaley S Morera, Martin S Hennig, Asif Talukder, et al.
BJU International|December 18, 2023
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancerChristian Vitug, Katherine Lajkosz, Julian Chavarriaga, et al.
The Journal of Urology|October 29, 2024
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder CancerEunice Villegas, Katherine Lajkosz, Shayan Din, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2018
Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic SignatureSoum D Lokeshwar, Asif Talukder, Travis J Yates, et al.
The Journal of Urology|December 14, 2012
A multi-institutional evaluation of active surveillance for low risk prostate cancerScott E Eggener, Alex Mueller, Ryan K Berglund, et al.
The Journal of Urology|February 24, 2009
A multi-institutional evaluation of active surveillance for low risk prostate cancerScott E Eggener, Alex Mueller, Ryan K Berglund, et al.
World Journal of Urology|August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancerMario I Fernández, Maurizio Brausi, Peter E Clark, et al.
Oncogenesis|May 20, 2020
Molecular targeting of renal cell carcinoma by an oral combinationAndre R Jordan, Jiaojiao Wang, Travis J Yates, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settingsCora N Sternberg, Joaquim Bellmunt, Guru Sonpavde, et al.
Cancer Cell International|December 29, 2022
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinomaJiaojiao Wang, Andre R Jordan, Huabin Zhu, et al.
British Journal of Cancer|October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targetsDaley S Morera, Martin S Hennig, Asif Talukder, et al.
BJU International|December 18, 2023
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancerChristian Vitug, Katherine Lajkosz, Julian Chavarriaga, et al.
The Journal of Urology|October 29, 2024
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder CancerEunice Villegas, Katherine Lajkosz, Shayan Din, et al.
Pageof 26